Cipla’s Q1 net profit increases 6 percent to Rs 478 crore
August 2019Cipla’s net profit has increased by 6 percent during the June quarter to Rs 478.19 crore. The company had also posted a profit of Rs 451.25 crore during the year-ago…Read More
Healthcare Buzz
-
-
Cadila Healthcare’s Q1 net declines by 75 percent
August 2019Cadila Healthcare Ltd. has reported a net profit of Rs 79 crore for the quarter ended June 2019, a sharp decline by about 75 percent from Rs 310 crore in…Read More
-
Sun Pharma permits licensing agreement to CMS
August 2019Sun Pharma Industries Ltd. has granted an exclusive license to a subsidiary of China Medical System Holdings Ltd. (CMS) to develop and commercialize seven generic products in Mainland China. The…Read More
-
Lonza India plans to double its turnover by 2024
August 2019Lonza India with turnover of 100 million CHF (Swiss Franc) has set the target of doubling its turnover by 2024 with an estimated growth of more than 15 percent. The…Read More
-
Cadila’s arm Alidac Pharma gets EIR for Ahmedabad unit
July 2019Cadila Healthcare’s manufacturing facility Alidac Pharmaceuticals Ltd. (Alidac), located at Pharmez, Ahmedabad, has received an establishment inspection report (EIR). The USFDA had conducted a pre-approval inspection (PAI) for doxorubicin liposomal,…Read More
-
Aurobindo Pharma to spend USD 200 million on CapEx in FY20
July 2019Aurobindo Pharma Limited will invest up to USD 200 million on CapEx and over 5 percent of sale value on research and development (R&D) during the current financial year. The…Read More
-
Brinton Pharmaceuticals receives Series B funding from India Alternatives
July 2019India Alternatives Investment Advisors Ltd. has invested up to USD 8 million for a significant minority stake in Brinton Pharmaceuticals Limited. Among the fastest-growing companies in the Indian pharmaceutical market,…Read More
-
Alembic Pharma to raise up to Rs 300 crore via NCDs
July 2019The board of Alembic Pharmaceuticals has approved raising of up to Rs 300 crore through issuance of non-convertible debentures (NCDs) on a private placement basis. The company will issue NCDs…Read More
-
Natco Pharma anticipates India, Brazil, Canada markets to be revenue drivers for FY20
July 2019Natco Pharma expects India, Brazil, and Canada markets to be its revenue drivers during the current financial year, recording growth of 30 percent to 40 percent. The India business alone…Read More
-
Lupin, Heritage recall drugs in US
July 2019Lupin has initiated a nationwide voluntary recall of pneumonia antibiotic in the US after a complaint of metal piece in the bottle was received. In a recent enforcement report, the…Read More
-
GSK gets USFDA nod for new administration options for Nucala Biologic
July 2019GlaxoSmithKline (GSK) has secured approval from the US Food and Drug Administration (USFDA) for two new methods for administering Nucala (mepolizumab), an auto-injector and a pre-filled safety syringe. Nucala is…Read More
-
Novartis India appoints Sanjay Murdeshwar as MD and VC
July 2019Novartis India has appointed Sanjay Murdeshwar as vice chairman and managing director of the company. Currently, he is Novartis’ country president in India and is responsible for the company’s pharmaceuticals…Read More
-
Merck Ltd. renamed as Procter & Gamble Health Ltd.
May 2019Merck Ltd. has been renamed as Procter & Gamble Health Ltd., following P&G’s global acquisition of the consumer health business of Merck KGaA, Germany. The company has received approval from…Read More
-
GSK Pharma Q4 net profit rises 16.56 percent to Rs 123 crore
May 2019GlaxoSmithKline Pharmaceuticals has reported a 16.56 percent rise in its standalone net profit to Rs 123.03 crore for the quarter ended March 31, 2019. The company had posted a net…Read More
-
Lupin records a 5 percent rise in FY 2019
May 2019Despite the pressure of business in the US, pharma major, Lupin Limited, recorded a 5.2 percent rise in revenues to Rs 16,369.4 crore in FY19, as compared to Rs 15,559.8…Read More
